Lactulose Aurobindo (Lactulose)

Lactulose is a synthetic sugar that reaches the colon unchanged. Gut bacteria ferment it into short‑chain fatty acids, which lower colonic pH and create an osmotic gradient that draws water into the lumen, softening stool. The acidic environment also converts ammonia to ammonium, reducing its absorption into the bloodstream.

The specific dose of Lactulose Aurobindo is determined by the prescribing healthcare professional based on the patient’s condition, age, renal and hepatic function, and response to therapy. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety data for Lactulose in pregnancy and lactation are limited. It is generally classified as a Category C medication, meaning risk cannot be ruled out. Healthcare providers should weigh the potential benefits against possible risks before prescribing it to pregnant or nursing mothers.

To order Lactulose Aurobindo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Lactulose is an osmotic laxative that works by drawing water into the colon, whereas stimulant laxatives such as bisacodyl increase intestinal motility. Compared with bulk‑forming agents like psyllium, lactulose provides a quicker onset of softening stool but may cause more gas and bloating. Choice depends on patient needs and tolerance.

Lactulose Aurobindo should be stored below 25°C in its original packaging, protected from moisture and direct heat. Keeping the product in a cool, dry place helps maintain its stability and effectiveness throughout its shelf life.

Lactulose Aurobindo is taken orally, usually as a liquid solution. It can be measured with a calibrated dose spoon or cup and taken with or without food, according to the prescribing clinician’s instructions.

The most serious risks include severe dehydration, electrolyte imbalances (especially low potassium), and rare allergic reactions. Patients should be monitored for signs of excessive fluid loss, muscle weakness, or any hypersensitivity symptoms and seek medical attention promptly if they occur.

Lactulose Aurobindo should be avoided in patients with known hypersensitivity to lactulose, those with intestinal obstruction, or severe hepatic failure where ammonia production cannot be adequately managed. It should also be used with caution in individuals with renal impairment or uncontrolled diabetes.